SLC51A

Chr 3AR

solute carrier family 51 member A

Also known as: OSTA, OSTalpha, PFIC6, SLC51A1

The SLC51A protein is an essential component of the Ost-alpha/Ost-beta transporter complex that exports bile acids from intestinal cells into portal blood circulation. Mutations cause progressive familial intrahepatic cholestasis type 6, a liver disease with autosomal recessive inheritance. The gene shows moderate constraint to loss-of-function variants (LOEUF 0.631), reflecting its important role in bile acid transport and enterohepatic circulation.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

?Cholestasis, progressive familial intrahepatic, 6MIM #619484
AR
0
Active trials
1
Pubs (1 yr)
89
P/LP submissions
0%
P/LP missense
0.63
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySLC51A
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.30) despite low pLI — interpret in context.
📋
ClinVar Variants
87 unique Pathogenic / Likely Pathogenic· 65 VUS of 196 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.63LOEUF
pLI 0.070
Z-score 2.65
OE 0.30 (0.160.63)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.22Z-score
OE missense 0.95 (0.851.08)
184 obs / 192.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.30 (0.160.63)
00.351.4
Missense OE0.95 (0.851.08)
00.61.4
Synonymous OE0.82
01.21.6
LoF obs/exp: 5 / 16.7Missense obs/exp: 184 / 192.8Syn Z: 1.32
DN
0.74top 25%
GOF
0.78top 25%
LOF
0.2288th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

196 submitted variants in ClinVar

Classification Summary

Pathogenic85
Likely Pathogenic2
VUS65
Likely Benign32
Benign4
Conflicting1
85
Pathogenic
2
Likely Pathogenic
65
VUS
32
Likely Benign
4
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
85
0
85
Likely Pathogenic
0
0
2
0
2
VUS
0
44
20
1
65
Likely Benign
0
6
13
13
32
Benign
0
1
1
2
4
Conflicting
1
Total05112116189

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLC51A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC